Hi Fyffee
So you are presuming dropouts due to side effects and those that can't get insurance cover will be will be replaced by newly identified Daybue and insurance covered patients to give 4500 long-term recipients of Daybue by 2027? That seems a brave forecast to me. I hope you are correct.
Neuren Media and Analyst Coverage, page-833
-
- There are more pages in this discussion • 535 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.14 |
Change
-0.040(0.30%) |
Mkt cap ! $1.679B | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.41 | $13.12 | $4.890M | 370.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 997 | $13.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.19 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |